Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 3 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Specimen Handling 64 Magnetic Resonance Spectroscopy 44 Carboplatin 34 Cyclophosphamide 31 Gemcitabine 29 Biopsy 28 Cisplatin 27 Radiotherapy 26 pembrolizumab 25 Bevacizumab 25 Paclitaxel 23 Standard of Care 22 Oxaliplatin 22 Drug Therapy 22 venetoclax 21 Nivolumab 21 Capecitabine 21 fludarabine 20 Injections 20 Interviews as Topic 18 Radiosurgery 16 Dexamethasone 16 Blood Specimen Collection 16 Azacitidine 16 toripalimab 15 tislelizumab 14 cemiplimab 13 anlotinib 13 Irinotecan 13 Pemetrexed 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Imlunestrant × 90 days × Clear all

NCT07287098 2026-05-22

preEMBER

Eli Lilly and Company

Phase 2 Not yet recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡